MARC Record from Library of Congress

LEADER: 12872cam a22004574a 4500
001 2008022786
003 DLC
005 20090604090130.0
008 080528s2009 caua be 001 0 eng
010 $a 2008022786
015 $aGBA8B6586$2bnb
016 7 $a101475123$2DNLM
016 7 $a014771781$2Uk
020 $a9781412950848 (cloth : alk. paper)
020 $a1412950848 (cloth : alk. paper)
035 $a(OCoLC)ocn185031308
040 $aDNLM/DLC$cDLC$dBTCTA$dBAKER$dYDXCP$dNLM$dNOR$dC#P$dOCLCQ$dUKM$dDLC
042 $apcc
050 00 $aRC563.4$b.E53 2009
082 00 $a362.2903$222
245 00 $aEncyclopedia of substance abuse prevention, treatment, & recovery /$cGary L. Fisher, Nancy A. Roget, editors.
246 3 $aEncyclopedia of substance abuse prevention, treatment, and recovery
260 $aLos Angeles :$bSAGE,$cc2009.
300 $a2 v. (xxxiii, 1092 p.) :$bill. ;$c29 cm.
500 $a"A SAGE reference publication."
504 $aIncludes bibliographical references and index.
505 00 $gv. 1 --$tList of entries --$tReader's guide --$tAbout the editors --$tContributors --$tIntroduction --$tEntries --$gv. 2 --$tList of entries --$tReader's guide --$tEntries --$tAppendix : Entries related to specific drugs --$tIndex.
505 00 $tAbstinence --$tAbstinence violation effect --$tAcamprosate --$tAcceptance and commitment therapy --$tAccess to recovery --$tAddiction, models of --$tAddiction severity index --$tAddiction technology transfer centers --$tAdolescents, substance abuse and treatment --$tAdult children of alcoholics --$tAfrican Americans, issues in prevention and treatment --$tAftercare --$tAl-Anon --$tAlateen --$tAlcohol --$tAlcoholic personality --$tAlcoholics Anonymous --$tAlcohol-induced disorders --$tAlcoholism --$tAlcohol marketing --$tAlcohol-related birth defects --$tAlcohol testing --$tAlcohol Use Disorders Identification Test --$tAlternative activities --$tAmerican Society of Addiction Medicine --$tAmotivational syndrome --$tAmphetamines --$tAmyl nitrite --$tAnabolic steroids --$tAnorexia nervosa --$tAntabuse (disulfiram) --$tAntianxiety agents --$tAntidepressant drugs --$tAntipsychotic drugs --$tAntiseizure drugs --$tAntisocial personality disorder --$tAnxiety disorders --$tAnxiolytic drugs --$tAsian Americans/Pacific Islanders, issues in prevention and treatment --$tAssessment --$tAssessment instruments --$tAthletes and drug use --$tAttention deficit hyperactivity disorder --$tAversive conditioning --$tAversive therapy --
505 00 $tBarbiturates --$tBehavioral couples therapy --$tBehavior risk factor surveillance system --$tBehavioral therapy --$tBenzodiazephines --$tBiculturalism --$tBig book, the --$tBill W. --$tBinge drinking --$tBiopsychosocial model of addiction --$tBlood alcohol concentration --$tBorderline personality disorder --$tBrain chemistry and addiction --$tBrief interventions --$tBrief strategic family therapy --$tBulimia nervosa --$tBuprenorphine --$tBusiness improvement practices --$tCaffeine --$tCAGE screening instrument --$tCannabinols --$tCannabis youth treatment study --$tCENAPS model --$tCenter for Substance Abuse Prevention --$tCenter for Substance Abuse Treatment --$tCenters for the Application of Prevention Technologies --$tCentral nervous system depressants --$tCentral nervous system stimulants --$tCertification and licensing --$tChemical dependency --$tChildren of alcoholics --$tChronicity --$tClient engagement --$tClient/treatment matching --$tClinical supervision of addiction counselors --$tClub drugs --$tCoalcoholic --$tCocaine and crack --$tCocaine Anonymous --$tCodependency --$tCoercion and treatment --$tCognitive behavioral therapy --$tCognitive-social learning model --$tCollege on Problems of Drug Dependence --$tCollege students, alcohol use and abuse --$tCollege students, drug use and abuse --$tCOMBINE study --
505 00 $tCommunity-based processes --$tCommunity reinforcement and family training --$tCommunity reinforcement approach --$tComprehensive Drug Abuse Prevention and Control Act of 1970 (Public Law 91-513) --$tConfidentiality --$tContingency management --$tContinuum of care --$tCo-occurring disorders --$tCounseling approaches --$tCourt-mandated treatment --$tCovert sensitization --$tCrack --$tCraving --$tCrime and substance abuse --$tCriminal justice populations --$tCross-addictions --$tCultural aspects --$tDecriminalization --$tDemand reduction --$tDenial --$tDepression --$tDetoxification --$tDiagnosis --$tDiagnostic and Statistical Manual of Mental Disorders --$tDisabilities, issues in prevention and treatment --$tDiscrimination, addicted and recovering individuals --$tDisease concept --$tDouble trouble --$tDriving under the influence --$tDriving while intoxicated --$tDrug abuse --$tDrug abuse resistance education --$tDrug abuse screening test --$tDrug abuse treatment outcome studies --$tDrug abuse warning network --$tDrug addiction --$tDrug courts --$tDrug-crime cycle --$tDrug-free Schools and Communities Act --$tDrug laws, history of --
505 00 $tDrugs, classification of --$tDrug testing --$tDrug use, history of --$tDry drunk syndrome --$tDual relationships --$tEating disorders --$tEconomic costs of alcohol and drug abuse --$tEcstasy --$tElderly populations, treatment issues --$tElectronic health records --$tEmpirically based prevention --$tEmpirically based treatment --$tEmployee Assistance Program --$tEnabling --$tEnvironmental approaches --$tEthical standards for addiction professionals --$tEthics --$tEvidence-based prevention --$tEvidence-based prevention and treatment, dissemination and adoption of --$tEvidence-based treatment --$tExpectancies --$tExperimental substance use --$tFamily behavior therapy --$tFamily counseling --$tFamily therapy --$tFentanyl --$tFetal alcohol syndrome --$tFetal effects of alcohol and other drugs --$tFidelity of prevention programs --
505 00 $tGamblers Anonymous --$tGambling, pathological --$tGambling, problem --$tGateway drugs theory --$tGay, lesbian, bisexual, and transgender issues --$tGender issues --$tGenetic aspects of addiction --$tGrief, loss, and substance abuse --$tGroup therapy and counseling --$tHallucinogens --$tHarm reduction, public health --$tHarm reduction psychotherapy --$tHashish --$tHealth care system and substance abuse --$tHealth Insurance Portability and Accountability Act --$tHepatitis C --$tHeroin --$tHigh-risk behaviors --$tHigh-risk situations --$tHispanics/Latinos, issues in prevention and treatment --$tHIV/AIDS --$tHomeless, substance abuse and treatment --$tIssues in prevention ; racial and ethnic minorities --$tIssues in treatment --$tIce --$tIllicit and illegal drugs --$tImpaired professionals --$tIndian health services --$tInformation dissemination --$tInformed consent --$tInhalants --$tInjection drug use --$tInpatient treatment --$tInstitute of Medicine Classification System --$tInternational Coalition for Addiction Studies Education --$tInternet addiction --$tIntervention --$tIntravenous drug use --$tInventory of drinking situations --
505 00 $tJellinek, E.M. --$tJohnson model intervention ---$tJoin Together --$tLegal Action Center --$tLegalization of drugs --$tLevo-alpha acetyl methadol --$tMarijuana --$tMaternal drug use --$tMatrix model --$tMedia campaigns --$tMedical consequences --$tMedical use of marijuana --$tMentoring --$tMethadone --$tMethadone maintenance treatment --$tMethamphetamine --$tMethods of drug administration --$tMichigan Alcohol Screening Test --$tMinnesota model --$tModeration approaches to alcohol problems --$tModeration in use --$tModeration management --$tMonitoring the future --$tMoral model --$tMorphine --$tMotivational enhancement therapy --$tMotivational interviewing --$tMulticulturalism --$tMultidimensional family therapy --
505 00 $tNAADAC, the Association for Addiction Professionals --$tNaloxone --$tNaltrexone --$tNarcotics Anonymous --$tNational Clearinghouse for Alcohol and Drug Information --$tNational Council on Alcoholism and Drug Dependence --$tNational Council on Problem Gambling --$tNational Drug Control Strategy --$tNational Epidemiologic Survey on Alcohol and Related Conditions --$tNational Gambling Impact Study Commission --$tNational Institute of Mental Health --$tNational Institute on Alcohol Abuse and Alcoholism --$tNational Institute on Drug Abuse --$tNational Institute on Drug Abuse Clinical Trials Network --$tNational media campaign --$tNational outcome measures --$tNational Registry of Evidence-based Programs and Practices --$tNational Survey on Drug Use and Health --$tNational Treatment Improvement Evaluation Study --$tNative Americans, issues in prevention and treatment --$tNatural recovery --$tNeedle exchange programs --$tNetwork for the improvement of addiction treatment --$tNeurobiology of addiction --$tNeurocognitive effects of alcohol and other drugs --$tNeurotransmitters --$tNicotine --$tNicotine replacement therapy --
505 00 $tOffice of National Drug Control Policy --$tOpiates --$tOpioids --$tOther addictions --$tOutpatient treatment --$tOver-the-counter drugs --$tOxyContin --$tPain management --$tPatient placement criteria --$tPeer recovery support services --$tPharmacological approaches to treatment --$tPhysiological aspects of drug use --$tPost-traumatic stress disorder --$tPrescription drugs --$tPrevention education --$tPrevention evaluation --$tPrevention populations --$tPrevention programs --$tPrevention strategies --$tProblem identification and referral --$tProblem oriented screening instrument for teenagers --$tProject MATCH --$tPsychological models of addiction --$tPsychosocial history --$tPublic policy, alcohol --$tPublic policy, drugs --$tPublic policy, prevention --$tPublic policy, treatment --$tPulse check --$tQualified services organization agreements --$tRacial and ethnic minorities, issues in alcohol and other drug use --$tRacial and ethnic minorities, issues in prevention --$tRapid opioid detoxification --$tRational recovery --$tRecovery --$tRecovery community organizations --$tRecovery community services program --$tRecovery schools --$tRecovery support services --$tRefusal skills --$tRelapse --$tRelapse prevention --$tResearch issues in prevention --$tResearch issues in treatment --$tResidential treatment --$tResistance in treatment --$tReverse tolerance --$tRisk and protective factor theory --$tRisk factors for addiction --$tRoutes of administration of drugs --
505 00 $tSchool-based prevention programs --$tSchool drug policies --$tScope of practice --$tScreening --$tScreening instruments --$tSecular organizations for sobriety/Save Our Selves --$tSedative-hypnotics --$tSelf-change --$tSelf-help groups --$tSelf-report inventories --$tSex addiction --$tSexually transmitted diseases --$tShopping addiction --$tSingle state authorities --$tSobriety --$tSocial drinking --$tSocial learning model of addictive behaviors --$tSocial norms marketing --$tSocial skills training --$tSociocultural models of addiction --$tSolution-focused therapy --$tSpecial populations --$tSpiritual issues --$tSpontaneous remission --$tStages of change model --$tState provider associations --$tSTD --$tSteroids --$tStigma --$tStudent assistance program --$tSubstance abuse --$tSubstance abuse and mental health services administration --$tSubstance abuse subtle screening inventory-3 --$tSubstance dependence --$tSubstance-induced disorders --$tSubstance-induced withdrawal delirium --$tSubstance use disorders --$tSubstitute addictions --$tSuicide --$tSupply reduction --$tSupport groups --$tSynanon --$tSynar amendment --
505 00 $tTherapeutic communities --$tTimeline followback --$tTobacco --$tTobacco cessation programs and treatments --$tTobacco marketing and countermarketing --$tTobacco master settlement agreement --$tTolerance --$tTreatment, history of --$tTreatment, nontraditional approaches --$tTreatment access and retention --$tTreatment approaches and strategies --$tTreatment effectiveness --$tTreatment facilities --$tTreatment in jails and prisons --$tTreatment of alcohol and drug use disorders --$tTreatment plans and treatment planning --$tTreatment programs for alcohol or drug abuse --$tTreatment settings --$tTuberculosis --$tTwelve-step facilitation --$tTwelve-step recovery programs --$tTwelve steps --$tUnderage drinking --$tUrine toxicology testing --$tVeterans, substance abuse and treatment --$tViolence, intimate partner and substance abuse treatment --$tViolence prevention --$tWar on drugs --$tWelfare reform and substance abuse --$tWillpower --$tWithdrawal --$tWomen for sobriety --$tWomens' issues in prevention and treatment --$tWorkplace drug policies --$tWorkplace drug use --$tWorkplace prevention.
650 0 $aSubstance abuse$vEncyclopedias.
650 12 $aSubstance-Related Disorders$vEncyclopedias$xEnglish.
700 1 $aFisher, Gary L.
700 1 $aRoget, Nancy A.